SECRETED FACTORS IN CARDIAC REMODELING PROVOKE TUMORIGENESIS AND END ORGAN DAMAGE IN HEART FAILURE

CORDIS oferuje możliwość skorzystania z odnośników do publicznie dostępnych publikacji i rezultatów projektów realizowanych w ramach programów ramowych HORYZONT.

Odnośniki do rezultatów i publikacji związanych z poszczególnymi projektami 7PR, a także odnośniki do niektórych konkretnych kategorii wyników, takich jak zbiory danych i oprogramowanie, są dynamicznie pobierane z systemu OpenAIRE .

Publikacje

Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta‐Analysis

Autorzy: Giacomo Tini, Edoardo Bertero, Alessio Signori, Maria Pia Sormani, Christoph Maack, Rudolf A. De Boer, Marco Canepa, Pietro Ameri
Opublikowane w: Journal of the American Heart Association, Numer 9, 2024, ISSN 2047-9980
Wydawca: Wiley-Blackwell
DOI: 10.1161/jaha.119.016309

Established Tumour Biomarkers Predict Cardiovascular Events and Mortality in the General Population

Autorzy: Valentina Bracun, Navin Suthahar, Canxia Shi, Sanne de Wit, Wouter C. Meijers, IJsbrand T. Klip, Rudolf A. de Boer, Joseph Pierre Aboumsallem
Opublikowane w: Frontiers in Cardiovascular Medicine, Numer 8, 2021, ISSN 2297-055X
Wydawca: Frontiers Media SA
DOI: 10.3389/fcvm.2021.753885

Circulating immune checkpoints predict heart failure outcomes

Autorzy: Elles M. Screever, Laura I.E. Yousif, Javid J. Moslehi, Joe‐Elie Salem, Adriaan A. Voors, Herman H.W. Silljé, Rudolf A. de Boer, Wouter C. Meijers
Opublikowane w: ESC Heart Failure, Numer 10, 2025, Strona(/y) 2330-2337, ISSN 2055-5822
Wydawca: Wiley
DOI: 10.1002/ehf2.14304

Longitudinal Changes in Circulating Ketone Body Levels in Patients With Acute Heart Failure: A Post Hoc Analysis of the EMPA-Response-AHF Trial

Autorzy: S.N. Voorrips, E.M. BOORSMA, J.C. BEUSEKAMP, R.A. DE-BOER, M.A. CONNELLY, R.P.F. DULLAART, P. VAN-DER-MEER, D.J. VAN-VELDHUISEN, A.A. VOORS, K. DAMMAN, B.D. WESTENBRINK
Opublikowane w: Journal of Cardiac Failure, Numer 29, 2024, Strona(/y) 33-41, ISSN 1071-9164
Wydawca: Churchill Livingstone
DOI: 10.1016/j.cardfail.2022.09.009

Insulin‐like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence

Autorzy: Valentina Bracun, Bart van Essen, Adriaan A. Voors, Dirk J. van Veldhuisen, Kenneth Dickstein, Faiez Zannad, Marco Metra, Stefan Anker, Nilesh J. Samani, Piotr Ponikowski, Gerasimos Filippatos, John G.F. Cleland, Chim C. Lang, Leong L. Ng, Canxia Shi, Sanne de Wit, Joseph Pierre Aboumsallem, Wouter C. Meijers, IJsbrand T. Klip, Peter van der Meer, Rudolf A. de Boer
Opublikowane w: ESC Heart Failure, Numer 9, 2025, Strona(/y) 4167-4176, ISSN 2055-5822
Wydawca: Wiley
DOI: 10.1002/ehf2.14120

Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice

Autorzy: Sanne de Wit, Lotte Geerlings, Canxia Shi, Just Dronkers, Elisabeth M Schouten, Gillian Blancke, Vanessa Andries, Tess Yntema, Wouter C Meijers, Debby P Y Koonen, Lars Vereecke, Herman H W Silljé, Joseph-Pierre Aboumsallem, Rudolf A de Boer
Opublikowane w: Cardiovascular Research, Numer 120, 2024, Strona(/y) 612-622, ISSN 0008-6363
Wydawca: Elsevier BV
DOI: 10.1093/cvr/cvae038

Tumour biomarkers: association with heart failure outcomes

Autorzy: C. Shi, H. H. van der Wal, H. H. W. Silljé, M. M. Dokter, F. van den Berg, L. Huizinga, M. Vriesema, J. Post, S. D. Anker, J. G. Cleland, L. L. Ng, N. J. Samani, K. Dickstein, F. Zannad, C. C. Lang, P. L. van Haelst, J. A. Gietema, M. Metra, P. Ameri, M. Canepa, D. J. van Veldhuisen, A. A. Voors, R. A. de Boer
Opublikowane w: Journal of Internal Medicine, Numer 288, 2023, Strona(/y) 207-218, ISSN 0954-6820
Wydawca: Blackwell Publishing Inc.
DOI: 10.1111/joim.13053

Relative fat mass, a new index of adiposity, is strongly associated with incident heart failure: data from PREVEND

Autorzy: Navin Suthahar, Laura M. G. Meems, Coenraad Withaar, Thomas M. Gorter, Lyanne M. Kieneker, Ron T. Gansevoort, Stephan J. L. Bakker, Dirk J. van Veldhuisen, Rudolf A. de Boer
Opublikowane w: Scientific Reports, Numer 12, 2022, ISSN 2045-2322
Wydawca: Nature Publishing Group
DOI: 10.1038/s41598-021-02409-6

Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart

Autorzy: Carlo Gabriele Tocchetti, Pietro Ameri, Rudolf A de Boer, Yuri D’Alessandra, Michele Russo, Daniela Sorriento, Michele Ciccarelli, Bernadett Kiss, Luc Bertrand, Dana Dawson, Ines Falcao-Pires, Mauro Giacca, Nazha Hamdani, Wolfgang A Linke, Manuel Mayr, Jolanda van der Velden, Serena Zacchigna, Alessandra Ghigo, Emilio Hirsch, Alexander R Lyon, Anikó Görbe, Péter Ferdinandy, Rosalinda Madonna,
Opublikowane w: Cardiovascular Research, Numer 116, 2020, Strona(/y) 1820-1834, ISSN 0008-6363
Wydawca: Elsevier BV
DOI: 10.1093/cvr/cvaa222

Mediators of the association between albuminuria and incident cancer: the PREVEND study

Autorzy: Li Luo, Priya Vart, Lyanne M Kieneker, Bert van der Vegt, Stephan J L Bakker, Eke G Gruppen, Niek F Casteleijn, Rudolf A de Boer, Navin Suthahar, Geertruida H de Bock, Joseph Pierre Aboumsallem, Ron T Gansevoort
Opublikowane w: Clinical Kidney Journal, Numer 17, 2024, ISSN 2048-8505
Wydawca: Oxford University Press
DOI: 10.1093/ckj/sfad295

Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies

Autorzy: Sanne de Wit, Claire Glen, Rudolf A de Boer, Ninian N Lang
Opublikowane w: Cardiovascular Research, Numer 118, 2023, Strona(/y) 3451-3466, ISSN 0008-6363
Wydawca: Elsevier BV
DOI: 10.1093/cvr/cvac132

Evaluation of renal cancer progression in a mouse model of heart failure

Autorzy: Canxia Shi, Joseph Pierre Aboumsallem, Sanne de Wit, Elisabeth Maria Schouten, Valentina Bracun, Wouter C. Meijers, Herman H.W. Silljé, Rudolf A. de Boer
Opublikowane w: Cancer Communications, Numer 41, 2023, Strona(/y) 796-799, ISSN 2523-3548
Wydawca: Wiley
DOI: 10.1002/cac2.12185

Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (<scp>HFA</scp>), European Society of Cardiology (<scp>ESC</scp>)

Autorzy: Wouter C. Meijers, Antoni Bayes‐Genis, Alexandre Mebazaa, Johann Bauersachs, John G.F. Cleland, Andrew J.S. Coats, James L. Januzzi, Alan S. Maisel, Kenneth McDonald, Thomas Mueller, A. Mark Richards, Petar Seferovic, Christian Mueller, Rudolf A. de Boer
Opublikowane w: European Journal of Heart Failure, Numer 23, 2023, Strona(/y) 1610-1632, ISSN 1388-9842
Wydawca: Elsevier BV
DOI: 10.1002/ejhf.2346

Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy

Autorzy: Niels Grote Beverborg, Daniela Später, Ralph Knöll, Alejandro Hidalgo, Steve T. Yeh, Zaher Elbeck, Herman H. W. Silljé, Tim R. Eijgenraam, Humam Siga, Magdalena Zurek, Malin Palmér, Susanne Pehrsson, Tamsin Albery, Nils Bomer, Martijn F. Hoes, Cornelis J. Boogerd, Michael Frisk, Eva van Rooij, Sagar Damle, William E. Louch, Qing-Dong Wang, Regina Fritsche-Danielson, Kenneth R. Chien, Kenny M.
Opublikowane w: Nature Communications, Numer 12, 2022, ISSN 2041-1723
Wydawca: Nature Publishing Group
DOI: 10.1038/s41467-021-25439-0

Autorzy: Navin Suthahar, Laura M.G. Meems, Jennifer E. Ho, Rudolf A. de Boer
Opublikowane w: European Journal of Heart Failure, Numer 22, 2023, Strona(/y) 775-788, ISSN 1388-9842
Wydawca: Elsevier BV
DOI: 10.1002/ejhf.1771

The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction

Autorzy: Coenraad Withaar, Laura M G Meems, George Markousis-Mavrogenis, Cornelis J Boogerd, Herman H W Silljé, Elisabeth M Schouten, Martin M Dokter, Adriaan A Voors, B Daan Westenbrink, Carolyn S P Lam, Rudolf A de Boer
Opublikowane w: Cardiovascular Research, Numer 117, 2022, Strona(/y) 2108-2124, ISSN 0008-6363
Wydawca: Elsevier BV
DOI: 10.1093/cvr/cvaa256

A Kinase Interacting Protein 1 (AKIP1) promotes cardiomyocyte elongation and physiological cardiac remodelling

Autorzy: Kirsten T. Nijholt, Pablo I. Sánchez-Aguilera, Harmen G. Booij, Silke U. Oberdorf-Maass, Martin M. Dokter, Anouk H. G. Wolters, Ben N. G. Giepmans, Wiek H. van Gilst, Joan H. Brown, Rudolf A. de Boer, Herman H. W. Silljé, B. Daan Westenbrink
Opublikowane w: Scientific Reports, Numer 13, 2023, ISSN 2045-2322
Wydawca: Nature Publishing Group
DOI: 10.1038/s41598-023-30514-1

Comorbidities complicating heart failure: changes over the last 15 years

Autorzy: Elles M. Screever, Martje H. L. van der Wal, Dirk J. van Veldhuisen, Tiny Jaarsma, Astrid Koops, Kuna S. van Dijk, Janke Warink-Riemersma, Jenifer E. Coster, B. Daan Westenbrink, Peter van der Meer, Rudolf A. de Boer, Wouter C. Meijers
Opublikowane w: Clinical Research in Cardiology, Numer 112, 2023, Strona(/y) 123-133, ISSN 1861-0684
Wydawca: Steinkopff
DOI: 10.1007/s00392-022-02076-1

Divergent effects of myostatin inhibition on cardiac and skeletal muscles in a mouse model of pressure overload

Autorzy: Canxia Shi, Sietske N. Zijlstra, Sanne de Wit, Wouter C. Meijers, Joseph Pierre Aboumsallem, Herman H. W. Silljé, Rudolf A. de Boer
Opublikowane w: American Journal of Physiology-Heart and Circulatory Physiology, Numer 325, 2023, Strona(/y) H195-H201, ISSN 0363-6135
Wydawca: American Physiological Society
DOI: 10.1152/ajpheart.00223.2023

Pectins from various sources inhibit galectin-3-related cardiac fibrosis

Autorzy: Carolin Pozder geb. Gehlken, A. Rogier van der Velde, Wouter C. Meijers, Herman H.W. Silljé, Pieter Muntendam, Martin M. Dokter, Wiek H. van Gilst, Henk A. Schols, Rudolf A. de Boer
Opublikowane w: Current Research in Translational Medicine, Numer 70, 2022, Strona(/y) 103321, ISSN 2452-3186
Wydawca: Elsevier BV
DOI: 10.1016/j.retram.2021.103321

Sex-specific aspects of phospholamban cardiomyopathy: The importance and prognostic value of low-voltage electrocardiograms

Autorzy: Remco de Brouwer, Laura M.G. Meems, Tom E. Verstraelen, Belend Mahmoud, Virginnio Proost, Arthur A.M. Wilde, Laurens P. Bosman, Esmée van Drie, Paul A. van der Zwaag, J. Peter van Tintelen, Arjan C. Houweling, Maarten P. van den Berg, Rudolf A. de Boer
Opublikowane w: Heart Rhythm, Numer 19, 2023, Strona(/y) 427-434, ISSN 1547-5271
Wydawca: Elsevier BV
DOI: 10.1016/j.hrthm.2021.11.009

The role of immune checkpoints in cardiovascular disease

Autorzy: Laura I. Yousif, Anniek A. Tanja, Rudolf A. de Boer, Arco J. Teske, Wouter C. Meijers
Opublikowane w: Frontiers in Pharmacology, Numer 13, 2022, ISSN 1663-9812
Wydawca: Frontiers Media S.A.
DOI: 10.3389/fphar.2022.989431

Urinary potassium excretion and mortality risk in community-dwelling individuals with and without obesity

Autorzy: Stanley MH Yeung, Anne Nooteboom, Ewout J Hoorn, Joris I Rotmans, Liffert Vogt, Rudolf A de Boer, Ron T Gansevoort, Gerjan Navis, Stephan JL Bakker, Martin H De Borst
Opublikowane w: The American Journal of Clinical Nutrition, Numer 116, 2023, Strona(/y) 741-749, ISSN 0002-9165
Wydawca: American Society for Clinical Nutrition, Inc.
DOI: 10.1093/ajcn/nqac137

Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the <scp>C</scp>ardio‐<scp>O</scp>ncology <scp>S</scp>tudy <scp>G</scp>roup of the <scp>H</scp>eart <scp>F</scp>ailure <scp>A</scp>ssociation of the <scp>E</scp>uropean <scp>S</scp>ociety of <scp>C</scp>ardiology in collaboration wi

Autorzy: Alexander R. Lyon, Susan Dent, Susannah Stanway, Helena Earl, Christine Brezden‐Masley, Alain Cohen‐Solal, Carlo G. Tocchetti, Javid J. Moslehi, John D. Groarke, Jutta Bergler‐Klein, Vincent Khoo, Li Ling Tan, Markus S. Anker, Stephan von Haehling, Christoph Maack, Radek Pudil, Ana Barac, Paaladinesh Thavendiranathan, Bonnie Ky, Tomas G. Neilan, Yury Belenkov, Stuart D. Rosen, Zaza Iakobishv
Opublikowane w: European Journal of Heart Failure, Numer 22, 2023, Strona(/y) 1945-1960, ISSN 1388-9842
Wydawca: Elsevier BV
DOI: 10.1002/ejhf.1920

Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)

Autorzy: Rudolf A. de Boer, Stephane Heymans, Johannes Backs, Lucie Carrier, Andrew J.S. Coats, Stefanie Dimmeler, Thomas Eschenhagen, Gerasimos Filippatos, Lior Gepstein, Jean‐Sebastien Hulot, Ralph Knöll, Christian Kupatt, Wolfgang A. Linke, Christine E. Seidman, C. Gabriele Tocchetti, Jolanda van der Velden, Roddy Walsh, Petar M. Seferovic, Thomas Thum
Opublikowane w: European Journal of Heart Failure, Numer 24, 2023, Strona(/y) 406-420, ISSN 1388-9842
Wydawca: Elsevier BV
DOI: 10.1002/ejhf.2414

Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)–Related Cardiomyopathy: Development of PLN-R14del–Related Cardiomyopathy

Autorzy: Tim R. Eijgenraam, Cornelis J. Boogerd, Nienke M. Stege, Vivian Oliveira Nunes Teixeira, Martin M. Dokter, Lukas E. Schmidt, Xiaoke Yin, Konstantinos Theofilatos, Manuel Mayr, Peter van der Meer, Eva van Rooij, Jolanda van der Velden, Herman H.W. Silljé, Rudolf A. de Boer
Opublikowane w: Circulation: Heart Failure, Numer 14, 2024, ISSN 1941-3297
Wydawca: Lippincott Williams & Wilkins Ltd.
DOI: 10.1161/circheartfailure.121.008532

DWORF Extends Life Span in a PLN-R14del Cardiomyopathy Mouse Model by Reducing Abnormal Sarcoplasmic Reticulum Clusters

Autorzy: Nienke M. Stege, Tim R. Eijgenraam, Vivian Oliveira Nunes Teixeira, Anna M. Feringa, Elisabeth M. Schouten, Diederik W.D. Kuster, Jolanda van der Velden, Anouk H.G. Wolters, Ben N.G. Giepmans, Catherine A. Makarewich, Rhonda Bassel-Duby, Eric N. Olson, Rudolf A. de Boer, Herman H.W. Silljé
Opublikowane w: Circulation Research, Numer 133, 2024, Strona(/y) 1006-1021, ISSN 0009-7330
Wydawca: Lippincott Williams & Wilkins Ltd.
DOI: 10.1161/circresaha.123.323304

Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study

Autorzy: Victor W Zwartkruis, Bastiaan Geelhoed, Navin Suthahar, Stephan J L Bakker, Ron T Gansevoort, Isabelle C van Gelder, Rudolf A de Boer, Michiel Rienstra
Opublikowane w: Open Heart, Numer 8, 2024, Strona(/y) e001786, ISSN 2053-3624
Wydawca: BMJ
DOI: 10.1136/openhrt-2021-001786

Multimarker profiling identifies protective and harmful immune processes in heart failure: findings from BIOSTAT-CHF

Autorzy: George Markousis-Mavrogenis, Jasper Tromp, Wouter Ouwerkerk, João Pedro Ferreira, Stefan D Anker, John G Cleland, Kenneth Dickstein, Gerasimos Filippatos, Chim C Lang, Marco Metra, Nilesh J Samani, null null, Rudolf A de Boer, Dirk J van Veldhuisen, Adriaan A Voors, Peter van der Meer
Opublikowane w: Cardiovascular Research, Numer 118, 2022, Strona(/y) 1964-1977, ISSN 0008-6363
Wydawca: Elsevier BV
DOI: 10.1093/cvr/cvab235

Diagnostic yield of a proactive strategy for early detection of cardiovascular disease versus usual care in adults with type 2 diabetes or chronic obstructive pulmonary disease in primary care in the Netherlands (RED-CVD): a multicentre, pragmatic, cluster-randomised, controlled trial

Autorzy: Amy Groenewegen, Victor W Zwartkruis, Michiel Rienstra, Nicolaas P A Zuithoff, Monika Hollander, Hendrik Koffijberg, Martijn Oude Wolcherink, Maarten J Cramer, Yvonne T van der Schouw, Arno W Hoes, Frans H Rutten, Rudolf A de Boer
Opublikowane w: The Lancet Public Health, Numer 9, 2024, Strona(/y) e88-e99, ISSN 2468-2667
Wydawca: Elsevier BV
DOI: 10.1016/s2468-2667(23)00269-4

Proactive screening for symptoms: A simple method to improve early detection of unrecognized cardiovascular disease in primary care. Results from the Lifelines Cohort Study

Autorzy: Victor W. Zwartkruis, Amy Groenewegen, Frans H. Rutten, Monika Hollander, Arno W. Hoes, M. Yldau van der Ende, Pim van der Harst, Maarten Jan Cramer, Yvonne T. van der Schouw, Hendrik Koffijberg, Michiel Rienstra, Rudolf A. de Boer
Opublikowane w: Preventive Medicine, Numer 138, 2022, Strona(/y) 106143, ISSN 0091-7435
Wydawca: Academic Press
DOI: 10.1016/j.ypmed.2020.106143

Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models

Autorzy: Coenraad Withaar, Carolyn S P Lam, Gabriele G Schiattarella, Rudolf A de Boer, Laura M G Meems
Opublikowane w: European Heart Journal, Numer 42, 2022, Strona(/y) 4420-4430, ISSN 0195-668X
Wydawca: Oxford University Press
DOI: 10.1093/eurheartj/ehab389

Sex differences in associations of comorbidities with incident cardiovascular disease: focus on absolute risk

Autorzy: Just Dronkers, Laura M G Meems, Dirk J van Veldhuisen, Sven Meyer, Lyanne M Kieneker, Ron T Gansevoort, Stephan J L Bakker, Michiel Rienstra, Rudolf A de Boer, Navin Suthahar
Opublikowane w: European Heart Journal Open, Numer 2, 2022, ISSN 2752-4191
Wydawca: Oxford University Press (OUP)
DOI: 10.1093/ehjopen/oeac017

Multi-omics analyses identify molecular signatures with prognostic values in different heart failure aetiologies

Autorzy: Joseph Pierre Aboumsallem, Canxia Shi, Sanne De Wit, George Markousis-Mavrogenis, Valentina Bracun, Tim R. Eijgenraam, Martijn F. Hoes, Wouter C. Meijers, Elles M. Screever, Marloes E. Schouten, Adriaan A. Voors, Herman H.W. Silljé, Rudolf A. De Boer
Opublikowane w: Journal of Molecular and Cellular Cardiology, Numer 175, 2024, Strona(/y) 13-28, ISSN 0022-2828
Wydawca: Academic Press
DOI: 10.1016/j.yjmcc.2022.12.001

Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkers

Autorzy: Canxia Shi, Joseph Pierre Aboumsallem, Navin Suthahar, Aniek O. de Graaf, Joop H. Jansen, Isabelle A. van Zeventer, Valentina Bracun, Sanne de Wit, Elles M. Screever, Pieter F. van den Berg, Wouter C. Meijers, Ron T. Gansevoort, Stephan J.L. Bakker, Pim van der Harst, Herman H.W. Silljé, Gerwin Huls, Rudolf A. de Boer
Opublikowane w: European Journal of Heart Failure, Numer 25, 2024, Strona(/y) 4-13, ISSN 1388-9842
Wydawca: Elsevier BV
DOI: 10.1002/ejhf.2715

Troponins and natriuretic peptides to detect cardiotoxicity: useful biomarkers or paradise lost?

Autorzy: Valentina Bracun, Rudolf A. de Boer
Opublikowane w: European Journal of Heart Failure, Numer 22, 2023, Strona(/y) 362-365, ISSN 1388-9842
Wydawca: Elsevier BV
DOI: 10.1002/ejhf.1676

Exercise: a molecular tool to boost muscle growth and mitochondrial performance in heart failure?

Autorzy: Kirsten T. Nijholt, Pablo I. Sánchez‐Aguilera, Suzanne N. Voorrips, Rudolf A. de Boer, B. Daan Westenbrink
Opublikowane w: European Journal of Heart Failure, Numer 24, 2023, Strona(/y) 287-298, ISSN 1388-9842
Wydawca: Elsevier BV
DOI: 10.1002/ejhf.2407

Unbiased complexome profiling and global proteomics analysis reveals mitochondrial impairment and potential changes at the intercalated disk in presymptomatic R14Δ/+ mice hearts

Autorzy: Brian Foo, Hugo Amedei, Surmeet Kaur, Samir Jaawan, Angela Boshnakovska, Tanja Gall, Rudolf A. de Boer, Herman H. W. Silljé, Henning Urlaub, Peter Rehling, Christof Lenz, Stephan E. Lehnart
Opublikowane w: PLOS ONE, Numer 19, 2024, Strona(/y) e0311203, ISSN 1932-6203
Wydawca: Public Library of Science
DOI: 10.1371/journal.pone.0311203

Could SGLT2 Inhibitors Improve Exercise Intolerance in Chronic Heart Failure?

Autorzy: Suzanne N. Voorrips, Huitzilihuitl Saucedo-Orozco, Pablo I. Sánchez-Aguilera, Rudolf A. De Boer, Peter Van der Meer, B. Daan Westenbrink
Opublikowane w: International Journal of Molecular Sciences, Numer 23, 2024, Strona(/y) 8631, ISSN 1422-0067
Wydawca: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms23158631

Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the <scp>Cardio‐Oncology Study Group</scp> of the <scp>Heart Failure Association</scp> and the <scp>Cardio‐Oncology Council of the European Society of Cardiology</scp>

Autorzy: Radek Pudil, Christian Mueller, Jelena Čelutkienė, Peter A. Henriksen, Dan Lenihan, Susan Dent, Ana Barac, Susanna Stanway, Javid Moslehi, Thomas M. Suter, Bonnie Ky, Martin Štěrba, Daniela Cardinale, Alain Cohen‐Solal, Carlo Gabriele Tocchetti, Dimitrios Farmakis, Jutta Bergler‐Klein, Markus S. Anker, Stephan Von Haehling, Yury Belenkov, Zaza Iakobishvili, Christoph Maack, Fortunato Ciard
Opublikowane w: European Journal of Heart Failure, Numer 22, 2023, Strona(/y) 1966-1983, ISSN 1388-9842
Wydawca: Elsevier BV
DOI: 10.1002/ejhf.2017

The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies

Autorzy: Nienke M. Stege, Rudolf A. de Boer, Maarten P. van den Berg, Herman H. W. Silljé
Opublikowane w: International Journal of Molecular Sciences, Numer 22, 2025, Strona(/y) 2955, ISSN 1422-0067
Wydawca: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms22062955

Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis

Autorzy: Sophie L van Veldhuisen, Thomas M Gorter, Gijs van Woerden, Rudolf A de Boer, Michiel Rienstra, Eric J Hazebroek, Dirk J van Veldhuisen
Opublikowane w: European Heart Journal, Numer 43, 2022, Strona(/y) 1955-1969, ISSN 0195-668X
Wydawca: Oxford University Press
DOI: 10.1093/eurheartj/ehac071

Galectin-3 and Blood Group: Binding Properties, Effects on Plasma Levels, and Consequences for Prognostic Performance

Autorzy: Carolin Pozder, Elles M. Screever, A. Rogier van der Velde, Herman H. Silljé, Janne Suwijn, Saskia de Rond, Marcus E. Kleber, Graciela Delgado, Jan Jacob Schuringa, Wiek H. van Gilst, Wouter C. Meijers, Winfried März, Rudolf A. de Boer
Opublikowane w: International Journal of Molecular Sciences, Numer 24, 2023, Strona(/y) 4415, ISSN 1422-0067
Wydawca: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms24054415

Progress in heart failure management in the Netherlands and beyond: long-term commitment to deliver high-quality research and patient care

Autorzy: L. M. G. Meems, D. J. van Veldhuisen, R. A. de Boer
Opublikowane w: Netherlands Heart Journal, Numer 28, 2022, Strona(/y) 31-38, ISSN 1568-5888
Wydawca: Mediselect B.V.
DOI: 10.1007/s12471-020-01453-7

Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues

Autorzy: Valentina Bracun, Joseph Pierre Aboumsallem, Peter van der Meer, Rudolf A. de Boer
Opublikowane w: Current Oncology Reports, Numer 22, 2022, ISSN 1523-3790
Wydawca: Current Science Inc.
DOI: 10.1007/s11912-020-00930-x

Common risk factors for heart failure and cancer

Autorzy: Wouter C Meijers, Rudolf A de Boer
Opublikowane w: Cardiovascular Research, Numer 115, 2022, Strona(/y) 844-853, ISSN 0008-6363
Wydawca: Elsevier BV
DOI: 10.1093/cvr/cvz035

Kidney Function in Patients With Neuromuscular Disease: Creatinine Versus Cystatin C

Autorzy: Elles M. Screever, Jenny E. Kootstra-Ros, Joyce Doorn, Jellie A. Nieuwenhuis, Henk E. J. Meulenbelt, Wouter C. Meijers, Rudolf A. de Boer
Opublikowane w: Frontiers in Neurology, Numer 12, 2021, ISSN 1664-2295
Wydawca: Frontiers Research Foundation
DOI: 10.3389/fneur.2021.688246

Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology

Autorzy: Arantxa González, A. Mark Richards, Rudolf A. de Boer, Thomas Thum, Henrike Arfsten, Martin Hülsmann, Inês Falcao‐Pires, Javier Díez, Roger S.Y. Foo, Mark Y. Chan, Alberto Aimo, Chukwuemeka G. Anene‐Nzelu, Magdy Abdelhamid, Stamatis Adamopoulos, Stefan D. Anker, Yuri Belenkov, Tuvia Ben Gal, Alain Cohen‐Solal, Michael Böhm, Ovidiu Chioncel, Victoria Delgado, Michele Emdin, Ewa A. Jankow
Opublikowane w: European Journal of Heart Failure, Numer 24, 2023, Strona(/y) 927-943, ISSN 1388-9842
Wydawca: Elsevier BV
DOI: 10.1002/ejhf.2493

Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction

Autorzy: Carolin Gehlken, Elles M. Screever, Navin Suthahar, Peter van der Meer, B. Daan Westenbrink, Jennifer E. Coster, Dirk J. Van Veldhuisen, Rudolf A. de Boer, Wouter C. Meijers
Opublikowane w: ESC Heart Failure, Numer 8, 2025, Strona(/y) 2458-2466, ISSN 2055-5822
Wydawca: Wiley
DOI: 10.1002/ehf2.13366

Cancer and heart disease: associations and relations

Autorzy: Rudolf A. de Boer, Wouter C. Meijers, Peter van der Meer, Dirk J. van Veldhuisen
Opublikowane w: European Journal of Heart Failure, Numer 21, 2023, Strona(/y) 1515-1525, ISSN 1388-9842
Wydawca: Elsevier BV
DOI: 10.1002/ejhf.1539

Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease

Autorzy: Joseph Pierre Aboumsallem, Javid Moslehi, Rudolf A. de Boer
Opublikowane w: Journal of the American Heart Association, Numer 9, 2024, ISSN 2047-9980
Wydawca: Wiley-Blackwell
DOI: 10.1161/jaha.119.013754

Associations of relative fat mass and BMI with all‐cause mortality: Confounding effect of muscle mass

Autorzy: Navin Suthahar, Victor Zwartkruis, Bastiaan Geelhoed, Coenraad Withaar, Laura M. G. Meems, Stephan J. L. Bakker, Ron T. Gansevoort, Dirk Jan van Veldhuisen, Michiel Rienstra, Rudolf A. de Boer
Opublikowane w: Obesity, Numer 32, 2024, Strona(/y) 603-611, ISSN 1930-7381
Wydawca: Wiley-Blackwell
DOI: 10.1002/oby.23953

Management of cardiac fibrosis is the largest unmet medical need in heart failure

Autorzy: Javier Díez, Rudolf A de Boer
Opublikowane w: Cardiovascular Research, Numer 118, 2022, Strona(/y) e20-e22, ISSN 0008-6363
Wydawca: Elsevier BV
DOI: 10.1093/cvr/cvab228

A new classification of cardio-oncology syndromes

Autorzy: Rudolf A. de Boer, Joseph Pierre Aboumsallem, Valentina Bracun, Douglas Leedy, Richard Cheng, Sahishnu Patel, David Rayan, Svetlana Zaharova, Jennifer Rymer, Jennifer M. Kwan, Joshua Levenson, Claudio Ronco, Paaladinesh Thavendiranathan, Sherry-Ann Brown
Opublikowane w: Cardio-Oncology, Numer 7, 2022, ISSN 2057-3804
Wydawca: Springer Science and Business Media LLC
DOI: 10.1186/s40959-021-00110-1

Reassessing the Mechanisms of PLN-R14del Cardiomyopathy

Autorzy: Nienke M. Stege, Rudolf A. de Boer, Catherine A. Makarewich, Peter van der Meer, Herman H.W. Silljé
Opublikowane w: JACC: Basic to Translational Science, Numer 9, 2024, Strona(/y) 1041-1052, ISSN 2452-302X
Wydawca: Elsevier BV
DOI: 10.1016/j.jacbts.2024.02.017

Shift work is associated with 10-year incidence of atrial fibrillation in younger but not older individuals from the general population: results from the Tromsø Study

Autorzy: Victor W Zwartkruis, Ekaterina Sharashova, Tom Wilsgaard, Rudolf A de Boer, Maja-Lisa Løchen, Michiel Rienstra
Opublikowane w: Open Heart, Numer 9, 2024, Strona(/y) e002086, ISSN 2053-3624
Wydawca: BMJ
DOI: 10.1136/openhrt-2022-002086

Being in Two Minds—The Challenge of Heart Failure with Preserved Ejection Fraction Diagnosis with a Single Biomarker

Autorzy: Navin Suthahar, Carsten Tschöpe, Rudolf A de Boer
Opublikowane w: Clinical Chemistry, Numer 67, 2021, Strona(/y) 46-49, ISSN 0009-9147
Wydawca: American Association for Clinical Chemistry, Inc.
DOI: 10.1093/clinchem/hvaa255

Associations of relative fat mass, a new index of adiposity, with type-2 diabetes in the general population

Autorzy: Navin Suthahar, Kan Wang, Victor W. Zwartkruis, Stephan J.L. Bakker, Silvio E. Inzucchi, Laura M.G. Meems, Tim R. Eijgenraam, Fariba Ahmadizar, Eric G. Sijbrands, Ron T. Gansevoort, Lyanne M. Kieneker, Dirk J. van Veldhuisen, Maryam Kavousi, Rudolf A. de Boer
Opublikowane w: European Journal of Internal Medicine, Numer 109, 2024, Strona(/y) 73-78, ISSN 0953-6205
Wydawca: Elsevier BV
DOI: 10.1016/j.ejim.2022.12.024

Preclinical Models of Cancer Therapy–Associated Cardiovascular Toxicity: A Scientific Statement From the American Heart Association

Autorzy: Aarti Asnani, Javid J. Moslehi, Bishow B. Adhikari, Alan H. Baik, Andreas M. Beyer, Rudolf A. de Boer, Alessandra Ghigo, Isabella M. Grumbach, Salvia Jain, Han Zhu, null null
Opublikowane w: Circulation Research, Numer 129, 2024, ISSN 0009-7330
Wydawca: Lippincott Williams & Wilkins Ltd.
DOI: 10.1161/res.0000000000000473

Exploring Cardiac Fibrosis

Autorzy: Rudolf A. de Boer, Reza Ardehali
Opublikowane w: JACC: Basic to Translational Science, Numer 9, 2024, Strona(/y) 1023-1025, ISSN 2452-302X
Wydawca: Elsevier BV
DOI: 10.1016/j.jacbts.2024.06.006

Current understanding of fibrosis in genetic cardiomyopathies

Autorzy: Tim R. Eijgenraam, Herman H.W. Silljé, Rudolf A. de Boer
Opublikowane w: Trends in Cardiovascular Medicine, Numer 30, 2022, Strona(/y) 353-361, ISSN 1050-1738
Wydawca: Elsevier BV
DOI: 10.1016/j.tcm.2019.09.003

A combined bioinformatics, experimental and clinical approach to identify novel cardiac‐specific heart failure biomarkers: is <scp>Dickkopf</scp>‐3 (<scp>DKK3</scp>) a possible candidate?

Autorzy: Arnold Piek, Navin Suthahar, Adriaan A. Voors, Rudolf A. de Boer, Herman H.W. Silljé
Opublikowane w: European Journal of Heart Failure, Numer 22, 2023, Strona(/y) 2065-2074, ISSN 1388-9842
Wydawca: Elsevier BV
DOI: 10.1002/ejhf.1988

Elevations of Cardiac Troponin in Patients Receiving Immune Checkpoint Inhibitors

Autorzy: Pieter F. van den Berg, Valentina Bracun, Michel Noordman, Peter van der Meer, Canxia Shi, Sjoukje F. Oosting, Joseph Pierre Aboumsallem, Sanne de Wit, Wouter C. Meijers, Mathilde Jalving, Michel van Kruchten, Rudolf A. de Boer
Opublikowane w: JACC: Advances, Numer 3, 2025, Strona(/y) 101375, ISSN 2772-963X
Wydawca: Elsevier BV
DOI: 10.1016/j.jacadv.2024.101375

Multiomics Analysis Provides Novel Pathways Related to Progression of Heart Failure

Autorzy: Wouter Ouwerkerk, Joao P. Belo Pereira, Troy Maasland, Johanna E. Emmens, Sylwia M. Figarska, Jasper Tromp, Andrea L. Koekemoer, Christopher P. Nelson, Mintu Nath, Simon P.R. Romaine, John G.F. Cleland, Faiez Zannad, Dirk J. van Veldhuisen, Chim C. Lang, Piotr Ponikowski, Gerasimos Filippatos, Stefan Anker, Marco Metra, Kenneth Dickstein, Leong L. Ng, Rudolf A. de Boer, Natal van Riel, Max Nieuwdo
Opublikowane w: Journal of the American College of Cardiology, Numer 82, 2024, Strona(/y) 1921-1931, ISSN 0735-1097
Wydawca: Elsevier BV
DOI: 10.1016/j.jacc.2023.08.053

Screening for Heart Failure: Biomarkers to Detect Heightened Risk in the General Population

Autorzy: Leah B. Kosyakovsky, Rudolf A. de Boer, Jennifer E. Ho
Opublikowane w: Current Heart Failure Reports, Numer 21, 2024, Strona(/y) 591-603, ISSN 1546-9530
Wydawca: Current Science Inc.
DOI: 10.1007/s11897-024-00686-6

Relationship between body mass index, cardiovascular biomarkers and incident heart failure

Autorzy: Navin Suthahar, Laura M.G. Meems, Dion Groothof, Stephan J.L. Bakker, Ron T. Gansevoort, Dirk J. van Veldhuisen, Rudolf A. de Boer
Opublikowane w: European Journal of Heart Failure, Numer 23, 2023, Strona(/y) 396-402, ISSN 1388-9842
Wydawca: Elsevier BV
DOI: 10.1002/ejhf.2102

A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers

Autorzy: Remco de Brouwer, Wouter P te Rijdt, Edgar T Hoorntje, Ahmad Amin, Folkert W Asselbergs, Moniek G P J Cox, Jeroen F van der Heijden, Hans Hillege, Jacco C Karper, Belend Mahmoud, Peter van der Meer, Anton Oomen, Anneline S J M te Riele, Herman H W Silljé, Hanno L Tan, Jan Peter van Tintelen, Dirk J van Veldhuisen, Berend Daan Westenbrink, Ans C P Wiesfeld, Tineke P Willems, Paul A van der Zwaag,
Opublikowane w: European Heart Journal, Numer 44, 2023, Strona(/y) 4284-4287, ISSN 0195-668X
Wydawca: Oxford University Press
DOI: 10.1093/eurheartj/ehad292

Sex-specific risk factors for new-onset heart failure: the PREVEND study at 25 years

Autorzy: Bart J van Essen, Johanna E Emmens, Jasper Tromp, Wouter Ouwerkerk, Marcelle D Smit, Christiane A Geluk, Lukas Baumhove, Navin Suthahar, Ron T Gansevoort, Stephan J L Bakker, Kevin Damman, Peter van der Meer, Rudolf A de Boer, Dirk J van Veldhuisen, Adriaan A Voors
Opublikowane w: European Heart Journal, Numer 46, 2025, Strona(/y) 1528-1536, ISSN 0195-668X
Wydawca: Oxford University Press
DOI: 10.1093/eurheartj/ehae868

Cardio-onco-metabolism: metabolic remodelling in cardiovascular disease and cancer

Autorzy: Anja Karlstaedt, Javid Moslehi, Rudolf A. de Boer
Opublikowane w: Nature Reviews Cardiology, Numer 19, 2022, Strona(/y) 414-425, ISSN 1759-5002
Wydawca: Nature Publishing Group
DOI: 10.1038/s41569-022-00698-6

High-Sensitivity Troponin-T and Cardiovascular Outcomes in the Community: Differences Between Women and Men

Autorzy: Navin Suthahar, Laura M.G. Meems, Dirk J. van Veldhuisen, Joan E. Walter, Ron T. Gansevoort, Stephane Heymans, Blanche Schroen, Pim van der Harst, Jenny E. Kootstra-Ros, Vanessa van Empel, Christian Mueller, Stephan J.L. Bakker, Rudolf A. de Boer
Opublikowane w: Mayo Clinic Proceedings, Numer 95, 2022, Strona(/y) 1158-1168, ISSN 0025-6196
Wydawca: Mayo Medical Ventures
DOI: 10.1016/j.mayocp.2020.01.017

Distinct pathophysiological pathways in women and men with heart failure

Autorzy: Alice Ravera, Bernadet T. Santema, Rudolf A. de Boer, Stefan D. Anker, Nilesh J. Samani, Chim C. Lang, Leong Ng, John G.F. Cleland, Kenneth Dickstein, Carolyn S.P. Lam, Harriette G. C. Van Spall, Gerasimos Filippatos, Dirk J. van Veldhuisen, Marco Metra, Adriaan A. Voors, Iziah E. Sama
Opublikowane w: European Journal of Heart Failure, Numer 24, 2023, Strona(/y) 1532-1544, ISSN 1388-9842
Wydawca: Elsevier BV
DOI: 10.1002/ejhf.2534

Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence

Autorzy: Nabil V Sayour, Ágnes M Paál, Pietro Ameri, Wouter C Meijers, Giorgio Minotti, Ioanna Andreadou, Antonella Lombardo, Massimiliano Camilli, Heinz Drexel, Erik Lerkevang Grove, Gheorghe Andrei Dan, Andreea Ivanescu, Anne Grete Semb, Gianluigi Savarese, Dobromir Dobrev, Filippo Crea, Juan-Carlos Kaski, Rudolf A de Boer, Péter Ferdinandy, Zoltán V Varga
Opublikowane w: European Heart Journal, Numer 45, 2024, Strona(/y) 1224-1240, ISSN 0195-668X
Wydawca: Oxford University Press
DOI: 10.1093/eurheartj/ehae105

Challenges in the diagnosis of heart failure with preserved ejection fraction in individuals with obesity

Autorzy: Bas M. van Dalen, Jie Fen Chin, Praveen A. Motiram, Anneke Hendrix, Mireille E. Emans, Jasper J. Brugts, B. Daan Westenbrink, Rudolf A. de Boer
Opublikowane w: Cardiovascular Diabetology, Numer 24, 2025, ISSN 1475-2840
Wydawca: BioMed Central
DOI: 10.1186/s12933-025-02612-z

Diagnostic role of echocardiography for patients with heart failure symptoms and preserved left ventricular ejection fraction

Autorzy: A. Hagendorff, S. Stöbe, J. Kandels, R. de Boer, C. Tschöpe
Opublikowane w: Herz, Numer 47, 2022, Strona(/y) 293-300, ISSN 0340-9937
Wydawca: Urban und Vogel Medien und Medizin Verlagsgesellschaft mbH
DOI: 10.1007/s00059-022-05118-6

Circulating bone morphogenetic protein 10 as a novel marker of atrial stress and remodelling in heart failure

Autorzy: Daan C H Ceelen, Valentina Bracun, Bart J van Essen, Adriaan A Voors, Rudolf A de Boer, Jozine M ter Maaten, Serge Masson, Peter Kastner, Chim C Lang, Navin Suthahar
Opublikowane w: Heart, Numer 111, 2025, Strona(/y) 172-179, ISSN 1355-6037
Wydawca: BMJ Publishing Group
DOI: 10.1136/heartjnl-2024-324486

Multifactorial Diseases of the Heart, Kidneys, Lungs, and Liver and Incident Cancer: Epidemiology and Shared Mechanisms

Autorzy: Canxia Shi, Sanne de Wit, Emina Učambarlić, George Markousis-Mavrogenis, Elles Screever, Wouter Meijers, Rudolf de Boer, Joseph Aboumsallem
Opublikowane w: Cancers, Numer 15, 2025, Strona(/y) 729, ISSN 2072-6694
Wydawca: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers15030729

A Kinase Interacting Protein 1 regulates mitochondrial protein levels in energy metabolism and promotes mitochondrial turnover after exercise

Autorzy: Kirsten T. Nijholt, Pablo I. Sánchez-Aguilera, Belend Mahmoud, Albert Gerding, Justina C. Wolters, Anouk H. G. Wolters, Ben N. G. Giepmans, Herman H. W. Silljé, Rudolf A. de Boer, Barbara M. Bakker, B. Daan Westenbrink
Opublikowane w: Scientific Reports, Numer 13, 2023, ISSN 2045-2322
Wydawca: Nature Publishing Group
DOI: 10.1038/s41598-023-45961-z

The emerging plasma biomarker Dickkopf-3 (DKK3) and its association with renal and cardiovascular disease in the general population

Autorzy: Arnold Piek, Leonie Smit, Navin Suthahar, Stephan J. L. Bakker, Rudolf A. de Boer, Herman H. W. Silljé
Opublikowane w: Scientific Reports, Numer 11, 2022, ISSN 2045-2322
Wydawca: Nature Publishing Group
DOI: 10.1038/s41598-021-88107-9

Risk Factors for Immune Checkpoint Inhibitor–Mediated Cardiovascular Toxicities

Autorzy: Laura I. Yousif, Elles M. Screever, Daniëlle Versluis, Joseph Pierre Aboumsallem, Stefan Nierkens, Olivier C. Manintveld, Rudolf A. de Boer, Wouter C. Meijers
Opublikowane w: Current Oncology Reports, Numer 25, 2023, Strona(/y) 753-763, ISSN 1523-3790
Wydawca: Current Science Inc.
DOI: 10.1007/s11912-023-01414-4

Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein Aggregation

Autorzy: Tim R. Eijgenraam, Nienke M. Stege, Vivian Oliveira Nunes Teixeira, Remco de Brouwer, Elisabeth M. Schouten, Niels Grote Beverborg, Liu Sun, Daniela Später, Ralph Knöll, Kenny M. Hansson, Carl Amilon, David Janzén, Steve T. Yeh, Adam E. Mullick, Peter van der Meer, Rudolf A. de Boer, Herman H. W. Silljé
Opublikowane w: International Journal of Molecular Sciences, Numer 23, 2024, Strona(/y) 2427, ISSN 1422-0067
Wydawca: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms23052427

Relative fat mass and prediction of incident atrial fibrillation, heart failure and coronary artery disease in the general population

Autorzy: Victor W. Zwartkruis, Navin Suthahar, Demy L. Idema, Belend Mahmoud, Colinda van Deutekom, Frans H. Rutten, Yvonne T. van der Schouw, Michiel Rienstra, Rudolf A. de Boer
Opublikowane w: International Journal of Obesity, Numer 47, 2023, Strona(/y) 1256-1262, ISSN 0307-0565
Wydawca: Nature Publishing Group
DOI: 10.1038/s41366-023-01380-8

Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart Failure

Autorzy: Pieter F. van den Berg, Joseph Pierre Aboumsallem, Elles M. Screever, Canxia Shi, Sanne de Wit, Valentina Bracun, Laura I. Yousif, Lotte Geerlings, Dongyu Wang, Jennifer E. Ho, Stephan J.L. Bakker, Bert van der Vegt, Herman H.W. Silljé, Rudolf A. de Boer, Wouter C. Meijers
Opublikowane w: JACC: CardioOncology, Numer 5, 2023, Strona(/y) 445-453, ISSN 2666-0873
Wydawca: Elsevier BV
DOI: 10.1016/j.jaccao.2023.03.015

Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy

Autorzy: Rafik Tadros, Sean L. Zheng, Christopher Grace, Paloma Jordà, Catherine Francis, Dominique M. West, Sean J. Jurgens, Kate L. Thomson, Andrew R. Harper, Elizabeth Ormondroyd, Xiao Xu, Pantazis I. Theotokis, Rachel J. Buchan, Kathryn A. McGurk, Francesco Mazzarotto, Beatrice Boschi, Elisabetta Pelo, Michael Lee, Michela Noseda, Amanda Varnava, Alexa M. C. Vermeer, Roddy Walsh, Ahmad S. Amin, Marjon
Opublikowane w: Nature Genetics, Numer 57, 2025, Strona(/y) 530-538, ISSN 1061-4036
Wydawca: Nature Publishing Group
DOI: 10.1038/s41588-025-02087-4

An increase in albuminuria is associated with a higher incidence of malignancies

Autorzy: Li Luo, Lyanne M Kieneker, Yuanhang Yang, Roemer J Janse, Alessandro Bosi, Rudolf A de Boer, Priya Vart, Juan-Jesus Carrero, Ron T Gansevoort
Opublikowane w: Clinical Kidney Journal, Numer 17, 2024, ISSN 2048-8505
Wydawca: Oxford University Press
DOI: 10.1093/ckj/sfae009

Pathophysiological pathways related to high plasma growth differentiation factor 15 concentrations in patients with heart failure

Autorzy: Daan Ceelen, Adriaan A. Voors, Jasper Tromp, Dirk J. van Veldhuisen, Kenneth Dickstein, Rudolf A. de Boer, Chim C. Lang, Stefan D. Anker, Leong L. Ng, Marco Metra, Piotr Ponikowski, Sylwia M. Figarska
Opublikowane w: European Journal of Heart Failure, Numer 24, 2023, Strona(/y) 308-320, ISSN 1388-9842
Wydawca: Elsevier BV
DOI: 10.1002/ejhf.2424

Hallmarks of cancer in patients with heart failure: data from BIOSTAT-CHF

Autorzy: P. F. van den Berg, L. I. Yousif, G. Markousis-Mavrogenis, C. Shi, V. Bracun, J. Tromp, S. de Wit, Y. Appels, E. M. Screever, J. P. Aboumsallem, W. Ouwerkerk, D. J. van Veldhuisen, H. H. W. Silljé, A. A. Voors, R. A. de Boer, Wouter C. Meijers
Opublikowane w: Cardio-Oncology, Numer 10, 2024, ISSN 2057-3804
Wydawca: Springer Science and Business Media LLC
DOI: 10.1186/s40959-024-00246-w

Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology

Autorzy: Andrew J S Coats, Stephane Heymans, Dimitrios Farmakis, Stefan D Anker, Johannes Backs, Johann Bauersachs, Rudolf A de Boer, Jelena Čelutkienė, John G F Cleland, Dobromir Dobrev, Isabelle C van Gelder, Stephan von Haehling, Gerhard Hindricks, Ewa Jankowska, Dipak Kotecha, Linda W van Laake, Mitja Lainscak, Lars H Lund, Ida Gjervold Lunde, Alexander R Lyon, Aristomenis Manouras, Davor Miličić,
Opublikowane w: European Heart Journal, Numer 43, 2022, Strona(/y) 863-867, ISSN 0195-668X
Wydawca: Oxford University Press
DOI: 10.1093/eurheartj/ehab834

The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy

Autorzy: Tim R. Eijgenraam, Bastiaan J. Boukens, Cornelis J. Boogerd, E. Marloes Schouten, Cees W. A. van de Kolk, Nienke M. Stege, Wouter P. te Rijdt, Edgar T. Hoorntje, Paul A. van der Zwaag, Eva van Rooij, J. Peter van Tintelen, Maarten P. van den Berg, Peter van der Meer, Jolanda van der Velden, Herman H. W. Silljé, Rudolf A. de Boer
Opublikowane w: Scientific Reports, Numer 10, 2022, ISSN 2045-2322
Wydawca: Nature Publishing Group
DOI: 10.1038/s41598-020-66656-9

Wyszukiwanie danych OpenAIRE...

Publikacje

Udostępnij tę stronę Udostępnij tę stronę w mediach społecznościowych

Pobierz Pobierz zawartość strony